ArticleJournal of translational medicine2019

Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice.

Estela Lorza-Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.